title: A minimal ING1b fragment that improves the efficacy of HDAC-based cancer cell killing.
authors.affiliation: Departments of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Boyko
authors.affiliation: Departments of Biochemistry and Molecular Biology, University of Calgary, Calgary, Alberta, Canada.|Department of Oncology, University of Calgary, Calgary, Alberta, Canada.
authors.forename: K
authors.initials: K
authors.lastname: Riabowol
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D056572:Histone Deacetylase Inhibitors / Q000494:pharmacology*; D006801:Humans; D000076023:Inhibitor of Growth Protein 1; D047908:Intracellular Signaling Peptides and Proteins / Q000737:chemistry / Q000494:pharmacology*; D009687:Nuclear Proteins / Q000737:chemistry / Q000494:pharmacology*; D010446:Peptide Fragments / Q000737:chemistry / Q000494:pharmacology*; D025521:Tumor Suppressor Proteins / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D056572:Histone Deacetylase Inhibitors; C501503:ING1 protein, human; D000076023:Inhibitor of Growth Protein 1; D047908:Intracellular Signaling Peptides and Proteins; D009687:Nuclear Proteins; D010446:Peptide Fragments; D025521:Tumor Suppressor Proteins